108 - References

References

110 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 References

1. Grover S, et al. Effectiveness of electroconvulsive therapy in patients with treatment resistant schizophrenia: a retrospective study. Psychiatry Res 2017; 249:349–353.
2. Petrides G, et al. Electroconvulsive therapy augmentation in clozapine-­resistant schizophrenia: a prospective, randomized study. Focus 2019; 17:76–82.
3. Zheng W, et al. Electroconvulsive therapy added to non-­clozapine antipsychotic medication for treatment resistant schizophrenia: meta-­ analysis of randomized controlled trials. PLoS One 2016; 11:e0156510.
4. Kim HS, et  al. Effectiveness of electroconvulsive therapy augmentation on clozapine-­resistant schizophrenia. Psychiatry Investig 2017; 14:58–62.
5. Vuksan Ćusa B, et al. The effects of electroconvulsive therapy augmentation of antipsychotic treatment on cognitive functions in patients with treatment-­resistant schizophrenia. J ECT 2018; 34:31–34.
6. Sinclair DJM, et al. Electroconvulsive therapy for treatment-­resistant schizophrenia. Schizophr Bull 2019; 45:730–732.
7. Grover S, et al. ECT in schizophrenia: a review of the evidence. Acta Neuropsychiatr 2019; 31:115–127.
8. Tharyan P, et al. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev 2005; (2):CD000076.
9. Chakrabarti S. Clozapine resistant schizophrenia: newer avenues of management. World J Psychiatry 2021; 11:429–448.
10. Lin HT, et al. Impacts of electroconvulsive therapy on 1-­year outcomes in patients with schizophrenia: a controlled, population-­based mirror-­ image study. Schizophr Bull 2018; 44:798–806.
11. Masoudzadeh A, et al. Comparative study of clozapine, electroshock and the combination of ECT with clozapine in treatment-­resistant schizophrenic patients. Pak J Biol Sci 2007; 10:4287–4290.
12. Kaster TS, et al. Clinical effectiveness and cognitive impact of electroconvulsive therapy for schizophrenia: a large retrospective study. J Clin Psychiatry 2017; 78:e383–e389.
13. Pawełczyk T, et al. Augmentation of antipsychotics with electroconvulsive therapy in treatment-­resistant schizophrenia patients with dominant negative symptoms: a pilot study of effectiveness. Neuropsychobiology 2014; 70:158–164.
14. Ahmed S, et al. Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-­clozapine) in treatment resistant schizophrenia: a comparative meta-­analysis. Heliyon 2017; 3:e00429.
15. Grover S, et  al. Augmentation strategies for clozapine resistance: a systematic review and meta-­analysis. Acta Neuropsychiatr 2023; 35:65–75.
16. Yeh TC, et al. Pharmacological and nonpharmacological augmentation treatments for clozapine-­resistant schizophrenia: a systematic review and network meta-­analysis with normalized entropy assessment. Asian J Psychiatr 2023; 79:103375.
17. Schoretsanitis G, et al. Lack of ECT effects on clozapine plasma levels in patients with treatment-­resistant schizophrenia: pharmacokinetic evidence from a randomized clinical trial. Schizophr Res 2020; 218:309–311.
18. Kay SR, et al. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261–276.
19. Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976.
20. Lally J, et al. Augmentation of clozapine with ECT: a retrospective case analysis. Acta Neuropsychiatr 2021; 33:31–36.
21. Overall JE, et al. The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10:812.
22. Lally J, et al. Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: a systematic review and meta-­ analysis. Schizophr Res 2016; 171:215–224.
23. Wang G, et al. ECT augmentation of clozapine for clozapine-­resistant schizophrenia: a meta-­analysis of randomized controlled trials. J Psychiatr Res 2018; 105:23–32.
24. Melzer-­Ribeiro DL, et al. Randomized, double-­blind, sham-­controlled trial to evaluate the efficacy and tolerability of electroconvulsive therapy in patients with clozapine-­resistant schizophrenia. Schizophr Res 2023; 268:252–260.
25. George R, et al. Examining the clinical effectiveness of continuation and maintenance electroconvulsive therapy in schizophrenia. Asian J Psychiatr 2024; 92:103895.
26. Zheng W, et al. Memory impairment following electroconvulsive therapy in Chinese patients with schizophrenia: meta-­analysis of randomized controlled trials. Perspect Psychiatr Care 2018; 54:107–114.
27. Sanghani SN, et  al. Electroconvulsive therapy (ECT) in schizophrenia: a review of recent literature. Curr Opin Psychiatry 2018; 31:213–222.
28. Zervas IM, et al. Using ECT in schizophrenia: a review from a clinical perspective. World J Biol Psychiatry 2012; 13:96–105.
29. Wagner E, et al. Clozapine combination and augmentation strategies in patients with schizophrenia-­recommendations from an international expert survey among the Treatment Response and Resistance in Psychosis (TRRIP) working group. Schizophr Bull 2020; 46:1459–1470.
30. Arumugham SS, et al. Efficacy and safety of combining clozapine with electrical or magnetic brain stimulation in treatment-­refractory schizophrenia. Expert Rev Clin Pharmacol 2016; 9:1245–1252.